KELLYE RITTER: Open Payments
NPI 1184128365 · NEW ORLEANS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$630 in 31 payments from 10 companies in 2025. Trend: 2023 $414 · 2024 $349 · 2025 $630
Food & beverage: $630
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 12 | $143 |
| Astellas Pharma US Inc | 3 | $139 |
| Biogen, Inc. | 1 | $125 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $58 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| MILLICENT US INC | 2 | $31 |
| Sage Therapeutics, LLC | 1 | $28 |
| Organon LLC | 1 | $27 |
| Evofem Biosciences, Inc. | 5 | $25 |
| Exeltis, USA Inc. | 1 | $18 |
Products named: ZURZUVAE, Veozah, MYFEMBREE, Mirena, JADA SYSTEM, Phexxi, Kyleena, SLYND.
Industry payments across LA — which companies pay providers there.
